Speculation is mounting that Johnson & Johnson could buy its Danish R&D partner Genmab, a pairing that has created the successful blood cancer drug Darzalex. J&J this year bought Swiss biotech ...

Mark Leiser is Healio's Oncology Insider, providing insightful analysis of therapeutic advances, clinical innovations, practice challenges and emerging trends that are shaping cancer care. With more ...